Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes.

Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes.

Item
http://www.wikidata.org/entity/Q34397063
Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular diseaseCyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitusAPOA-I: a possible novel biomarker for metabolic side effects in first episode schizophrenia.Forkhead box C2 promoter variant c.-512C>T is associated with increased susceptibility to chronic venous diseasesPPIA rs6850: A > G single-nucleotide polymorphism is associated with raised plasma cyclophilin A levels in patients with coronary artery disease.Arterialization and anomalous vein wall remodeling in varicose veins is associated with upregulated FoxC2-Dll4 pathway.Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes MellitusImmunoproteomic identification and characterization of Ni2+-regulated proteins implicates Ni2+ in the induction of monocyte cell death.Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline.Introduction to personalized medicine in diabetes mellitus.Cyclophilin A: a key player for human diseaseCyclophilin A and EMMPRIN (CD147) in cardiovascular diseases.Activity rhythms and masking response in the diurnal fat sand rat under laboratory conditions.Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorder.Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.Platelet-bound cyclophilin A in patients with stable coronary artery disease and acute myocardial infarction.
P2860

Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes.

Item
http://www.wikidata.org/entity/Q34397063
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Proteomic profiling of high gl ...... flammation in type 2 diabetes.
@ast
Proteomic profiling of high gl ...... flammation in type 2 diabetes.
@en
Proteomic profiling of high gl ...... flammation in type 2 diabetes.
@nl
type
label
Proteomic profiling of high gl ...... flammation in type 2 diabetes.
@ast
Proteomic profiling of high gl ...... flammation in type 2 diabetes.
@en
Proteomic profiling of high gl ...... flammation in type 2 diabetes.
@nl
prefLabel
Proteomic profiling of high gl ...... flammation in type 2 diabetes.
@ast
Proteomic profiling of high gl ...... flammation in type 2 diabetes.
@en
Proteomic profiling of high gl ...... flammation in type 2 diabetes.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Proteomic profiling of high gl ...... nflammation in type 2 diabetes
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921